Recent studies on pediatric acute myeloid leukemia (pAML) have revealed pediatric-specific
driver alterations, many of which are underrepresented in the current classification schemas …

Acute myeloid leukemia (AML) is a very heterogeneous hematological malignancy that
accounts for approximately 20% of all pediatric leukemia cases. The outcome of pediatric …

Acute myeloid leukemia (AML) is a heterogeneous disease with a genetic, epigenetic, and
transcriptional etiology mainly presenting somatic and germline abnormalities. AML …

Simple Summary In children after intensive chemotherapy for acute leukemias (AL) or
undergoing hematopoietic cell transplantation (HCT), the prognostic impact of 12 serum iron …

Acute myeloid leukemia (AML) accounts for approximately 15–20% of all childhood
leukemia cases. The overall survival of children with acute myeloid leukemia does not …

New methods like panel-based RNA fusion sequencing (RNA-FS) promise improved
diagnostics in various malignancies. We here analyzed the impact of RNA-FS on the initial …

Data from 200 children with high‐risk acute myeloid leukaemia who underwent their first
haploidentical haematopoietic stem cell transplantation (haplo‐HSCT) between 2015 and …

Acute myeloid leukemia (AML) is a disease that mainly affects elderly patients who are more
often unfit for intensive chemotherapy (median age of diagnosis is 68). The regimens …

TCRαβ/CD19 cell depletion is a promising graft manipulation technique frequently used in
the context of human leukocyte antigen (HLA)–haploidentical hematopoietic stem cell …

The benefit of three-drug induction chemotherapy over a two-drug induction has not been
evaluated in pediatric acute myeloid leukemia (AML). We, therefore, conducted a …